Nursing and Health Professions
Disease Management
100%
Mucocutaneous Lymph Node Syndrome
100%
Coronary Artery Aneurysm
100%
Alka-Seltzer
66%
Practice Guideline
66%
Knowledge Base
33%
Statin (Protein)
33%
Dual Antiplatelet Therapy
33%
Disease Registry
33%
Low Drug Dose
33%
Anticoagulation
33%
Clopidogrel
33%
Beta Adrenergic Receptor Blocking Agent
33%
Anticoagulant Therapy
33%
Warfarin
33%
Low Molecular Weight Heparin
33%
Medicine and Dentistry
Kawasaki Disease
100%
Coronary Artery Aneurysm
100%
Acetylsalicylic Acid
66%
Antiplatelet
66%
Coronary Artery
66%
Base
33%
Low Drug Dose
33%
Statin
33%
Anticoagulation
33%
Warfarin
33%
Beta Adrenergic Receptor Blocking Agent
33%
Anticoagulant Therapy
33%
Thromboprophylaxis
33%
Low Molecular Weight Heparin
33%
Clopidogrel
33%
Keyphrases
Medical Management
100%
Risk Level
100%
Kawasaki Disease
100%
Coronary Artery Aneurysm
100%
Anticoagulation
14%
Knowledge Translation
14%
Translation Effort
14%
Clopidogrel
7%
Warfarin
7%
Beta-blockers
7%
Thromboprophylaxis
7%
Patient Characteristics
7%
Long-term Management
7%
Coronary Artery
7%
Disease Registry
7%
Triple Therapy
7%
Statin Use
7%
Acetylsalicylic Acid
7%
American Heart Association Guidelines
7%
Absence of Evidence
7%
Low Molecular Weight Heparin
7%
Media Risk
7%
Dual Antiplatelet Therapy
7%
Coronary Artery Diameter
7%
Association Risk
7%
Dual Antiplatelet
7%
Low-dose Acetylsalicylic Acid
7%
Pharmacology, Toxicology and Pharmaceutical Science
Mucocutaneous Lymph Node Syndrome
100%
Coronary Artery Aneurysm
100%
Antiplatelet
66%
Acetylsalicylic Acid
66%
Clopidogrel
33%
Anticoagulation Therapy
33%
Statin (Protein)
33%
Beta Adrenergic Receptor Blocking Agent
33%
Base
33%
Warfarin
33%
Low Molecular Weight Heparin
33%